Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications
- PMID: 20591509
- DOI: 10.1016/j.tips.2010.05.008
Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications
Abstract
Peripheral mechanisms of endogenous pain control are significant. In peripheral inflamed tissue, an interaction between immune-cell-derived opioids and opioid receptors localized on sensory nerve terminals results in potent, clinically measurable analgesia. Opioid peptides and the mRNA encoding their precursor proteins are present in immune cells. These cells 'home' preferentially to injured tissue, where they secrete opioids to reduce pain. Investigation of the mechanisms underlying the migration of opioid-containing immune cells to inflamed tissue is an active area of research, with recent data demonstrating the importance of cell adhesion molecules in leukocyte adhesion to both the endothelium in vascular transmigration and to neurons within peripheral inflamed tissue. This review summarizes the physiological mechanisms and clinical significance of this unique endogenous peripheral analgesic pathway and discusses therapeutic implications for the development of novel targeted peripheral analgesics.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Targeting of opioid-producing leukocytes for pain control.Neuropeptides. 2007 Dec;41(6):355-63. doi: 10.1016/j.npep.2007.06.001. Epub 2007 Jul 20. Neuropeptides. 2007. PMID: 17640727 Review.
-
Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects.Brain Behav Immun. 2010 Jul;24(5):683-94. doi: 10.1016/j.bbi.2009.10.013. Epub 2009 Oct 29. Brain Behav Immun. 2010. PMID: 19879349 Review.
-
Peripheral mechanisms of opioid analgesia.Curr Opin Pharmacol. 2009 Feb;9(1):3-8. doi: 10.1016/j.coph.2008.12.009. Epub 2009 Jan 20. Curr Opin Pharmacol. 2009. PMID: 19157985 Review.
-
Leukocytes in the regulation of pain and analgesia.J Leukoc Biol. 2005 Dec;78(6):1215-22. doi: 10.1189/jlb.0405223. Epub 2005 Oct 4. J Leukoc Biol. 2005. PMID: 16204636 Review.
-
Opioids and sensory nerves.Handb Exp Pharmacol. 2009;(194):495-518. doi: 10.1007/978-3-540-79090-7_14. Handb Exp Pharmacol. 2009. PMID: 19655116 Review.
Cited by
-
The use of lipid-based nanocarriers for targeted pain therapies.Front Pharmacol. 2013 Nov 21;4:143. doi: 10.3389/fphar.2013.00143. Front Pharmacol. 2013. PMID: 24319430 Free PMC article. Review.
-
Pain-novel targets and new technologies.Front Pharmacol. 2014 Sep 16;5:211. doi: 10.3389/fphar.2014.00211. eCollection 2014. Front Pharmacol. 2014. PMID: 25278897 Free PMC article. No abstract available.
-
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea.PLoS One. 2013;8(1):e54807. doi: 10.1371/journal.pone.0054807. Epub 2013 Jan 29. PLoS One. 2013. PMID: 23382975 Free PMC article. Clinical Trial.
-
The opioid peptide dynorphin A induces leukocyte responses via integrin Mac-1 (αMβ2, CD11b/CD18).Mol Pain. 2015 Jun 3;11:33. doi: 10.1186/s12990-015-0027-0. Mol Pain. 2015. PMID: 26036990 Free PMC article.
-
Peripherally Acting Opioids in Orofacial Pain.Front Neurosci. 2021 May 4;15:665445. doi: 10.3389/fnins.2021.665445. eCollection 2021. Front Neurosci. 2021. PMID: 34017236 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical